Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125839762 | 12583976 | 2 | F | 20150101 | 20160915 | 20160722 | 20160919 | EXP | PHHY2015EC050733 | NOVARTIS | 43.84 | YR | M | Y | 0.00000 | 20160919 | CN | COUNTRY NOT SPECIFIED | EC |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125839762 | 12583976 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 319800 | MG | D | 22068 | 400 | MG | CAPSULE | BID | |||
125839762 | 12583976 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, QD | 319800 | MG | D | 22068 | 200 | MG | CAPSULE | QD | |||
125839762 | 12583976 | 3 | SS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, Q48H | 319800 | MG | D | 22068 | 200 | MG | CAPSULE | ||||
125839762 | 12583976 | 4 | SS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, QD | 319800 | MG | D | 22068 | 200 | MG | CAPSULE | QD | |||
125839762 | 12583976 | 5 | SS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, BID | 319800 | MG | D | 22068 | 200 | MG | CAPSULE | BID | |||
125839762 | 12583976 | 6 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 319800 | MG | D | 22068 | 400 | MG | CAPSULE | BID | |||
125839762 | 12583976 | 7 | SS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, TID | 319800 | MG | D | 22068 | 200 | MG | CAPSULE | TID | |||
125839762 | 12583976 | 8 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 319800 | MG | D | 22068 | 400 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125839762 | 12583976 | 1 | Chronic myeloid leukaemia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125839762 | 12583976 | Arthralgia | |
125839762 | 12583976 | Back pain | |
125839762 | 12583976 | Chest pain | |
125839762 | 12583976 | Headache | |
125839762 | 12583976 | Hyperhidrosis | |
125839762 | 12583976 | Incorrect drug administration duration | |
125839762 | 12583976 | Influenza | |
125839762 | 12583976 | Oropharyngeal pain | |
125839762 | 12583976 | Pain | |
125839762 | 12583976 | Pyrexia | |
125839762 | 12583976 | Urinary tract disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125839762 | 12583976 | 1 | 20141030 | 20150708 | 0 | |
125839762 | 12583976 | 2 | 20150709 | 20150807 | 0 | |
125839762 | 12583976 | 3 | 20150909 | 20160211 | 0 | |
125839762 | 12583976 | 4 | 20160212 | 20160512 | 0 | |
125839762 | 12583976 | 5 | 20160513 | 20160608 | 0 | |
125839762 | 12583976 | 6 | 20160609 | 20160707 | 0 | |
125839762 | 12583976 | 7 | 20160708 | 20160807 | 0 | |
125839762 | 12583976 | 8 | 20160808 | 20160910 | 0 |